Total body irradiation (TBI) at bone marrow transplantation (BMT) is shown to cause salivary gland dysfunction in children. The aim of the investigation was to study the function of major salivary glands in long-term surviving children following treatment with TBI, using salivary gland scintigraphy (SGS). Thirteen patients (seven male, six female), who had received TBI before the age of 13 years and survived more than 4 years, participated in the study. A reference group of 10 patients (nine male, one female) was examined shortly before they were to undergo BMT. The mean age was 14.1 ± 4.1 years in the TBI-treated group and 12.8 ± 5.9 years in the reference group. Unstimulated and stimulated whole salivary secretion rates were measured for 15 and 5 min, respectively, before SGS was performed. The percentage of stimulated secretion was 44.7 ± 18.1% in the TBI-treated group compared to 58.4 ± 13.0% in the reference group (P = 0.0438). Slower reaccumulation after excretion was found in the TBItreated patients compared to the reference group (P = 0.0300). The function of the major salivary glands in long-term survivors treated with TBI at BMT before the age of 13 years was found to be diminished, as shown by the reduced trapping rate and reduced emptying capacity, compared to prior to BMT. Bone Marrow Transplantation (2000) 26, 775-779.
gland dysfunction are common acute effects found in this patient group. Salivary gland dysfunction, dentofacial malformations and temporomandibular dysfunction are longterm oral complications after pediatric BMT. 8, 9 Irradiation is one major cause of salivary gland dysfunction in BMT patients. 3, 10 In a study by Jones et al 11 that followed adult patients conditioned with chemotherapy and TBI, normal levels of salivary secretions were found 2 years after BMT. Among pediatric BMT recipients conditioned with TBI in combination with chemotherapy, a permanent dysfunction of the salivary glands is seen. 12 For this group of patients, a lifelong oral preventive care program is necessary to avoid development of oral complications.
To evaluate the degree of salivary dysfunction, 99m-technetium pertechnetate (99mTc) salivary gland scintigraphy (SGS) has been used in the study of patients with radiation-induced salivary gland dysfunction 13, 14 and Sjög-ren's syndrome. 15, 16 SGS is a well-documented method and allows an objective, noninvasive, simultaneous, and continuous functional study of the major salivary glands. 17, 18 The aim of the present study was to study functional disturbances of the major salivary glands using 99mTc SGS in children surviving long-term who were treated with TBI and BMT.
Patients and methods
One hundred and thirteen children under the age of 13 years underwent allogeneic BMT at Huddinge University Hospital between November 1979 and March 1993. One hundred and one patients received grafts from HLA-identical siblings and 12 from HLA-A, -B and -DR compatible unrelated donors. 19 Sixty-five of the 113 patients received (7.5, 8 or 10 Gy) single-dose TBI as conditioning therapy. TBI was combined with CY (120 mg/kg) 1 in all patients, except one who received TBI in combination with BU/vincristine. Thirty-three of the children in the TBI group had died before the present study was started. Twenty-one of the remaining 32 long-term (more than 4 years) surviving patients in the TBI group attended the Department of Pediatric Dentistry for oral health examinations during the study period between January 1994 and March 1997. Children under the age of seven years were not expected to tolerate the examination procedure and were therefore excluded. One patient was excluded because an SGS had recently been performed outside the study protocol. Fifteen of the remaining 20 patients agreed to participate in the study. Two of them, however, were unable to cooperate during the scintigraphic examination. Characteristics of the 13 (seven male, six female) patients examined are shown in Table 1 . They had all received grafts from HLA-identical siblings. 19 Conditioning therapy with CY combined with 10 Gy TBI was given to all patients examined except for two who had Gaucher's disease; they were given 8 Gy instead. 20 Conditioning, immunosuppression, and patient care have been previously described in detail. 1, 19, 20, 21 Either the patients in the study had not developed chronic GVHD or it had resolved and immunosuppressive therapy had been discontinued. The reference group consisted of 10 (nine male, one female) patients who were examined shortly before they were to undergo BMT (Table 1) . It was not possible to use healthy children as a control group for ethical reasons, since radioactive material was used. The patients examined before BMT were planned to be included in a longitudinal study of salivary function, which is why it was justified to include them in the study.
All participants and parents gave their informed consent. Approval was obtained from the ethical committee of Huddinge University Hospital.
Patients were instructed not to eat, drink, put anything in the mouth, or brush their teeth for at least 90 min before the examination. Saliva was collected in a quiet examination room at the Department of Pediatric Dentistry between 7.30 and 9.30 a.m. Unstimulated whole saliva was collected over 15 min. The patients were advised that a very small amount of saliva would ooze into their mouth in the unstimulated state and that the objective of the test was to measure the rate of flow of this secretion, which was why they should not swallow during this procedure. They were told to sit still, bow their head, and try not to move during the test. Immediately before the test they were instructed to swallow all residual saliva. The saliva was allowed to accumulate in the mouth and the patient was asked to gently spit saliva into the collecting vessel approximately once a minute. The volume was recorded and the unstimu- lated whole salivary secretion rate (USSR) was expressed as ml/min. After a 5-min break, stimulated whole saliva was collected. Prior to collecting stimulated saliva patients chewed paraffin wax (1.5 g, melting point 42°C, Orion Diagnostica, Espoo, Finland) for 1 min and were instructed to swallow that saliva. Stimulated whole saliva was then collected during a 5-min period. The patient was told not to swallow, and gently spit the stimulated saliva into a collecting vessel. The volume was recorded and the stimulated whole salivary secretion rate (SSSR) was calculated as ml/min. A USSR less than or equal to 0.1 ml/min and an SSSR less than or equal to 0.5 ml/min were considered abnormal. 22 Directly after the clinical examination at the Department of Pediatric Dentistry, SGS was performed at the Department of Nuclear Medicine, Huddinge University Hospital. Scintigraphy was performed with a gamma camera (Maxicamera II; General Electric Medical Systems, Milwaukee, WI, USA) equipped with a low energy all-purpose (LEAP) collimator. The patient was placed in the supine position with the gamma camera placed close above the face to record activity in the major salivary glands and surrounding tissues. The radioactive isotope 99mTc was injected intravenously. The dose administered varied between 77 and 200 MBq depending on the weight of the patient. The effective dose equivalent was less than 2.2 mSv. Forty-five minutes after the injection, one ml of 5% citric acid was applied to the subjects' tongue to accelerate excretion. Two subjects received citric acid after 30 min, because of problems with co-operation.
Collection of the digitized data began immediately at injection and was continued at 30-s intervals for 60 min. The data were later replayed to obtain time-activity curves of each region of interest. Background radiation was subtracted using the temporal region for the parotid glands and the area above the thyroid gland for the submandibular glands.
Analyses of time-activity curves were made according to a previously described method.
15,23 Figure 1 shows measured uptake levels, velocity of tracer accumulation and excretion, and percentage excretion after stimulation.
Statistical analyses
The Mann-Whitney U test was used to compare salivary secretion rates and scintigraphic values from the two groups of patients. Pearson's correlation test was performed to analyze the correlation between continuous variables. The data were not tested for normality.
Results
Stimulated and unstimulated salivary secretion rates are shown in Table 2 . There were significant differences between the reference-and TBI-treated groups regarding both USSR (P = 0.0324) and SSSR (P = 0.0101). Abnormal USSR (р0.1 ml/min) were found in seven patients in the TBI group and one patient in the reference group. Seven TBI-treated patients but none of the patients in the reference group were found to have abnormal SSSR (р0.5 Figure 1 All variables in the time-activity curve (TAC) were calculated using a computer. Maximum uptake (Ma) was defined as the highest uptake value in the TAC. Prestimulated uptake (Pu) was measured as the uptake value immediately before stimulation and minimum uptake (Mi) as the lowest uptake value after stimulation. The uptake level at the end of the study, 15 min after stimulation, was designated as the final uptake (Fu). The up-slope (US) represents the direction coefficient (d.c.) between 1.5 and 3.5 min after injection of the isotope and the prestimulation-slope (PS) the d.c. during steady state the 6.5 min before Pu. The stimulated down-slope (DS) was defined as the d.c. between the application of citric acid (Pu) and Mi. The reaccumulation-slope (RS) was defined as the d.c. between Mi and the level reached 6.5 min later. The percentage stimulated secretion (S) was calculated as S = (1 − Mi/Ma) × 100%. 15 The time to maximum uptake (TMa) was measured from injection of the isotope until Ma was reached. All values are presented as percent of total dose injected (%ID).
Table 2
Mean value, standard deviation and range for unstimulated (USSR) and stimulated (SSSR) salivary secretion rates among children and adolescents just prior to BMT (reference group) and after TBI (TBI group) ml/min). Only four TBI-treated patients had normal levels for both USSR and SSSR. Neither the USSR (0.19 ± 0.09 ml/min) nor the SSSR (0.72 ± 0.16 ml/min) of the five TBItreated patients who did not want to participate in the scintigraphic examination was significantly different from those of the 13 patients in the TBI group who did participate in the scintigraphic study. Table 3 shows the mean values of measured variables Table 3 Mean values with standard deviations and ranges of scintigraphic variables from the time-activity curves of the two groups studied
Reference

Reference group TBI group
Up slope (US) (%ID/s × 10 Bone Marrow Transplantation from the time-activity curves for the two groups examined. The percentage stimulated secretion (S) was significantly lower (P = 0.0438) in the TBI-treated group compared to the reference group. The reaccumulation slope (RS) was significantly steeper in the reference group (P = 0.0300) compared to the TBI group. Neither maximum nor minimum uptake levels showed any significant differences between groups. There were no significant gender differences regarding any of the analyzed variables within the different groups.
Age at BMT showed a significant positive correlation to SSSR (P = 0.0278). The age at scintigraphic examination showed a significant correlation to SSSR (P = 0.0238), minimal uptake (Mi) after stimulation (P = 0.0189), down slope (DS) after stimulation (P = 0.0436), and percentage stimulated secretion (S) (P = 0.0152).
Discussion
This is the first time salivary gland scintigraphy has been used to analyze salivary gland function in children and adolescents surviving long term following BMT. At present there is no other method available for the study of the physiological function of the salivary glands.
There were no differences regarding either USSR or SSSR between the TBI-treated patients who participated in this study and those who had not wanted to participate in the scintigraphic study.
The reference group had a dominance of male participants. Heintze et al 24 found no gender differences in SSSR among patients 15-24 years of age. They did, however, find a correlation between USSR and gender in patients 15 years and over but no significant correlation between secretion rate and age. 24 Crossner 25 found a significant correlation between gender and SSSR in all age groups from 5 to 15 years. He showed that boys at the age of 13-14 years (comparable to our study group) expressed a mean SSSR value 19-23% higher compared with the girls. We found in a previous study 10 of pediatric BMT patients (range 4-12 years of age) that the SSSR was lower among the girls. The difference between the sexes was not significant before BMT, but 1 year after pediatric BMT the girls were found to have significantly lower SSSR. 10 The dominance of male participants in the present study might have decreased the difference between the TBI group and the reference group. In the present study, however, there were no significant gender differences in any of the analyzed variables within the different groups.
Whole saliva may not be the ideal sample for analysis for every purpose. It is, however, collected simply and provides clinically relevant information. 26 Single gland saliva collection is more difficult and has a higher value in cases where the composition of saliva from an individual gland is to be studied, but this was not the subject of the present study.
The lower secretion rates in the TBI group -both USSR and SSSR -is in agreement with our previously reported results, indicating that salivary gland dysfunction in longterm surviving children who have undergone TBI might be permanent. 12 The decreased secretory capacity (S) in the TBI-treated group indicates a decreased capacity on emptying the glands after stimulation. A chronic defect in the irradiated glands due to accumulation of fibrotic tissue may be an explanation for the different excretion pattern. The steeper rate of reaccumulation in the reference group after the nonirradiated gland was emptied might be explained both by fibrotic damage of the irradiated glands and by an acute effect from cytotoxic treatment, resulting in an increased blood flow and a faster accumulation of tracer in the glands. Additional radiation damage of the salivary gland components cannot be excluded. In patients treated with radiation therapy for head and neck cancers, Valdés Olmos et al 13 found that the excretion response following stimulation was significantly correlated to radiation dose. A significantly reduced rate of secretion was found in our study of longterm survivors who had undergone 8 or 10 Gy TBI at BMT before 12 years of age, indicating that the risk of permanent damage to the salivary gland function at these doses is high.
There was no correlation in the TBI group between USSR or SSSR and time elapsed since TBI. This supports our previous finding 12 that there is no recovery of salivary gland function following TBI.
In conclusion, the scintigraphic findings of the percentage stimulated secretion (S) and reaccumulation slope (RS) were significantly lower among TBI-treated children and adolescents than in patients examined just prior to BMT. Salivary gland scintigraphy visualizes decreased function of the major salivary glands in long-term survivors treated with TBI at BMT.
The risk of oral mucosal damage -through trauma and fungal or viral infections -increases when salivary secretion is lowered. Swallowing and taste acuity may be impaired and quality of life may be poorer. 27, 28 Risk of dental caries increases when salivary secretion rate is decreased. 29 In some patients a rampant carious process may lead to infections that may be hazardous to immunocompromised subjects. Through a careful dental preventive care program -including oral hygiene treatment, antimicrobial treatment, topical fluoride application and dietary counseling -dental caries prevalence can be held at a level similar to that found in healthy children. 12 Salivary stimulating products and sometimes saliva substitutes should be considered to help patients deal with their problems.
